Your browser doesn't support javascript.
loading
Curcumin nanoformulations: Beneficial nanomedicine against cancer.
Maleki Dizaj, Solmaz; Alipour, Mahdieh; Dalir Abdolahinia, Elaheh; Ahmadian, Elham; Eftekhari, Aziz; Forouhandeh, Haleh; Rahbar Saadat, Yalda; Sharifi, Simin; Zununi Vahed, Sepideh.
Afiliação
  • Maleki Dizaj S; Dental and Periodontal Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Alipour M; Department of Dental Biomaterials, Faculty of Dentistry, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Dalir Abdolahinia E; Dental and Periodontal Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Ahmadian E; Research Center for Pharmaceutical Nanotechnology, Biomedicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Eftekhari A; Kidney Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Forouhandeh H; Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Rahbar Saadat Y; Health innovation and acceleration center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Sharifi S; Russian Institute for Advanced Study, Moscow State Pedagogical University, Moscow, Russian Federation.
  • Zununi Vahed S; Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
Phytother Res ; 36(3): 1156-1181, 2022 Mar.
Article em En | MEDLINE | ID: mdl-35129230
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Curcumina / Nanopartículas / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Curcumina / Nanopartículas / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article